Clearmind Medicine

CMND · NASDAQ

$5.87−$0.13 (−2.17%)TodayMarket closed · Oct 23, 7:37 PM ET

Prev close $6.00

About CMND

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.

Employees: 0
Headquarters: Vancouver, Ontario
Listed: Aug 10, 2021
Sector: Health Care
Industry: Pharmaceuticals
Website: clearmindmedicine.com

Leadership

Clearmind Medicine executives
Name	Title	Age
Amitay Weiss	—	65
Adi Zuloff-Shani	—	59
Alan Rootenberg	—	74
Prof. Mark Haden	—	73
Hila Kironrevach	—	46
Oz Adler	—	41
Asaf Itzhaik	—	55
Yehonatan Shachar	—	36

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.